NBIX quarterly revenue hits $1 billion on Ingrezza, CRENESSITY growth
Quarterly revenue reached $1 billion, led by strong growth in Ingrezza, CRENESSITY, and VYKAT XR. Ingrezza remains in double-digit growth; CRENESSITY exceeded expectations with robust adoption and persistency.